Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cobalamin transport proteins are a group of specialized carrier proteins responsible for the binding, protection, plasma transport, intestinal absorption, lysosomal export, and cellular delivery of cobalamin (vitamin B12) in mammals. The three main extracellular human cobalamin-binding proteins are haptocorrin, intrinsic factor, and transcobalamin. Each has a distinct role: • **Haptocorrin** binds dietary cobalamins in saliva/stomach. • **Intrinsic factor** binds dietary cobalamins after gastric passage; this complex is absorbed by ileal enterocytes via the cubilin receptor. • **Transcobalamin** binds newly absorbed or circulating free cobalamins for delivery to tissues through interaction with the transcobalamin receptor on cell surfaces. Additionally, intracellular trafficking involves lysosomal exporters such as ABCD4 and its escort LMBD1 that move internalized vitamin B12 from lysosomes into the cytosol for metabolic use. These proteins share a two-domain architecture that creates a high-affinity binding site at their domain interface. Dysfunction—whether genetic or acquired—in any step involving these carriers or their associated receptors leads to clinical syndromes characterized by impaired red blood cell formation and neurological deficits due to defective tissue supply of active vitamin B12. Note on correctness: "Cobalamin transport proteins" is not itself a single canonical target but rather refers collectively to several distinct but related carrier molecules—each with its own gene/protein name. For structured data purposes it is preferable to specify individual members such as "Transcoblamin," "Intrinsic factor," etc., rather than using this plural/generic form.
Facilitate the binding, transport, and receptor-mediated endocytosis of vitamin B12 from dietary sources into circulation and then into target cells via specific carrier proteins and their receptors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cobalamin transport protein.